Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.
Novo-Semide (March 05, 2010)
- Starting date:
- March 05, 2010
- Posting date:
- March 29, 2010
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-2010A108
Reason
Lots found to contain some out-of-weight specification tablets.
Depth of distribution
Wholesalers and pharmacies. No export
Affected products
Novo-Semide
DIN, NPN, DIN-HIM
DIN 00337730
Dosage form
Tablet
Strength
- 20 mg
Lot or serial number
35307857A, 35307858A, 35307858B, 35307858C
Companies
- Recalling Firm
- Teva Canada Limited
30 Novopharm Court
Toronto Ontario
Canada M1B 2K9
- Marketing Authorization Holder
- Teva Canada Limited
30 Novopharm Court
Toronto Ontario
Canada M1B 2K9
- Date modified: